• Formulated the desired R&D portfolio (list of products to have in the future) and a plan to achieve it• Planned and promoted high-quality projects according to priority ranking• Licensed in multiple products following advanced exploration and assessment of in-licensing candidates• Established Maruho Pharmaceutical Technology (Beijing) Co., Ltd. in China as a business base for global markets• Built a system to optimize production strategies based on the long-term development of each product• Strengthened the approach and structure for stable supply by establishing a system to evaluate the supply risks of all items, including raw materials, and creating a stable supply manual• Formulated Reliability Assurance Policy• Prepared an annual report covering the reliability assurance departments to confirm compliance with laws and regulations and understand the operation and management status• Obtained and shared evidence regarding the inhibition of scar formation by BEPIO Gel and Epiduo Gel• Fostered an optimal medical environment by supporting collaboration among medical professionals in areas nationwide, starting with skin diseases• Planned and prepared to launch an informative site that comprehensively addresses skin concerns, including information on Maruho’s prescription drugs and skin care products.• Implemented measures such as internal job postings and voluntary training• Instilled Corporate Philosophy within the company through Town Hall Meetings (THMs) and other occasions and promoted inter-departmental collaboration through workshops and other means• Established an employee FAQ site to improve work efficiency and productivity• Communicated the company’s stance and initiatives, such as Environmental Policy and Reliability Assurance Policy, aiming to be a company trusted and respected by societyFiscal year ended September 2024 results1. Maruho’s Meaning of Existence2. Value Creation 3. Strategy for ProspectsValue Creation4. FeatureWe will execute licensing and R&D action plans based on the target product positioning and build an appropriate R&D portfolio. We will promote development activities according to priority and aim to continuously launch new products. At the same time, we will continue to explore and acquire new products while strengthening our network with domestic and overseas pharmaceutical companies, venture companies, and academia. In global markets, we will strengthen functions to advance our businesses overseas, while speeding up our expansion in Asia.To optimize our production strategy, we will consider the division of roles and measures for our four-plant system while keeping a keen eye on the external environment, and verify its effectiveness. In addition, in order to further pursue stable supply and reduced quality risks, we will invest in the acquisition of advanced production technologies and improvements in production efficiency. We will raise awareness internally about the Reliability Assurance Policy formulated in the fiscal year ended September 2024 with the aim of having all employees continue implementing it as a matter of course and promoting its greater evolution.To help new products grow, we will use digital technology to provide information tailored to individual circumstances. In addition, in light of the start of Japan’s selective treatment system for long-listed drugs, we will accelerate the provision of valuable information to consumers, including patients, in addition to medical professionals.In the future, to address a wider range of skin concerns, we will build and expand our skin science platform, with a view to creating synergies with our individual businesses, such as diagnostics, medical devices, and cosmetics.To respect and develop autonomous human resources, we will support more employees to create their own career plans based on the results of the engagement survey “More Smiles” and THMs. While promoting employee autonomy, we will foster a workplace culture with the same mentality that encourages all employees to participate in training. We will promote the operation of the introduced system to improve work efficiency and productivity and enable employees to focus on their core duties.Challenges and future initiatives5. Foundation for :For SmilesSustainable Growth6. Business Performance and Financial Information7. Company InformationMaruho Report 202422
元のページ ../index.html#23